CN102772511B - Traditional Chinese medicine composition for treating mumps - Google Patents
Traditional Chinese medicine composition for treating mumps Download PDFInfo
- Publication number
- CN102772511B CN102772511B CN2012102912239A CN201210291223A CN102772511B CN 102772511 B CN102772511 B CN 102772511B CN 2012102912239 A CN2012102912239 A CN 2012102912239A CN 201210291223 A CN201210291223 A CN 201210291223A CN 102772511 B CN102772511 B CN 102772511B
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- parts
- chinese medicine
- mumps
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating mumps. The traditional Chinese medicine composition is prepared from lindley butterflybush herb, radix isatidis, drymoglossum piloselloides, radix bupleuri, mock strawberry, rhizoma menispermi, leaves of Chinese hibiscus, rhizoma cimicifugae, cicada slough and rhizoma et radix notopterygii. The traditional Chinese medicine composition disclosed by the invention can be used for treating the mumps in clinic.
Description
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese medicine composition for the treatment of mumps.
Background technology
Mumps is called again mumps, is a kind of child and the teenager respiratory infectious disease common in winter and spring, also is found in the adult.Its main manifestations is heating, enlargement under the ear-lobe of one or both sides, and the parotid gland of enlargement often is hemispherical, blur margin centered by ear-lobe, surface heat has angle pain, dehisce or while chewing part feel pain, it is meningitis, orchitis and oophoritis that the minority complication is arranged.Study carefully its pathogenic factor, Chinese medicine thinks that the evil poison of pathogenic wind-warm, from the muzzle invasion, inside attacks few sun, stops up resistance shaoyang channel arteries and veins, with QI and blood, fights mutually, and cheek under the ear that stagnates, become this disease eventually.Through inventor's long-term practice, draw, Chinese medicine is controlled mumps and is had better effect, obtains good effect.
Summary of the invention
The object of the present invention is to provide the Chinese medicine composition of the treatment mumps that a kind of therapeutic effect is good, effective percentage is high, human body is had no side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilize the property of medicine of Chinese medicine uniqueness, adopt Herba Buddlejae Lindleyanae, Radix Isatidis, Drymoglossum Herba Drymoglossi, Radix Bupleuri, Herba Duchesneae Indicae, Rhizoma Menispermi, Folium Hibisci Rosae-Sinensis, Rhizoma Cimicifugae, Periostracum Cicadae, Rhizoma Et Radix Notopterygii according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention and make Herba Buddlejae Lindleyanae 30-50 part, Radix Isatidis 20-40 part, Drymoglossum Herba Drymoglossi 20-30 part, Radix Bupleuri 10-30 part, Herba Duchesneae Indicae 15-25 part, Rhizoma Menispermi 15-25 part, Folium Hibisci Rosae-Sinensis 10-20 part, Rhizoma Cimicifugae 10-20 part, Periostracum Cicadae 8-15 part, Rhizoma Et Radix Notopterygii 8-15 part by following raw material medicaments.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: 40 parts of Herba Buddlejae Lindleyanaes, 30 parts of Radix Isatidis, 25 parts of Drymoglossum Herba Drymoglossis, 20 parts of Radix Bupleuri, 20 parts of Herba Duchesneae Indicaes, 20 parts of Rhizoma Menispermis, 15 parts of Folium Hibisci Rosae-Sinensiss, 15 parts of Rhizoma Cimicifugaes, 10 parts of Periostracum Cicadaes, 10 parts of Rhizoma Et Radix Notopterygiis.The pharmacological action of Chinese medicine of the present invention is as follows:
Herba Buddlejae Lindleyanae: acrid, bitter, warm.Dispel the wind removing toxic substances, anthelmintic, change bone is hard.Mumps, carbuncle, scrofula disease, ascariasis, ancylostomiasis, all fishbone fishbones.
Radix Isatidis: bitter, cold.Return liver, stomach warp.Heat-clearing and toxic substances removing, the removing heat from blood sore-throat relieving.For maculae caused by violent heat pathogen, high heat headache, major part pestilence, scarlet fever, erysipelas, mumps, sore throat, skin ulcer is swollen etc.
Drymoglossum Herba Drymoglossi: sweet, light, micro-cool.Return liver, lung meridian.Heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, hemostasis.For jaundice due to damp-heat, conjunctival congestion and swelling pain, parotitis, lymphadenitis, traumatic injury.
Radix Bupleuri: bitter, hot, be slightly cold, return liver, gallbladder meridian.Evacuation is brought down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI.For stagnation of QI due to depression of the liver, pain in chest and hypochondrium.
Herba Duchesneae Indicae: sweet, bitter, cold.Return lung, liver, large intestine channel.Heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, cooling blood for hemostasis.Calentura, infantile convulsion, cough, spit blood, laryngopharynx swelling and pain, dysentery, carbuncle, furuncle, snake bite and insect sting, burn and scald, flu, jaundice, conjunctival congestion, aphtha, mumps, furuncle and phyma, metrorrhagia, menoxenia, treating swelling and pain by traumatic injury.
Rhizoma Menispermi: bitter, cold, slightly poisonous.Return lung, stomach, large intestine channel.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain, dampness removing.For laryngopharynx swelling and pain, cough due to lung-heat, mumps, dysentery, jaundice, rheumatic arthralgia, swelling and pain of hemorrhoid, snake bite and insect sting etc.
Folium Hibisci Rosae-Sinensis: sweet, light, flat.GUIXIN, Liver Channel.Clearing away heat-damp and promoting diuresis, removing toxic substances.For leucorrhea, stranguria, furuncle swelling toxin, parotitis, mastitis, lymphadenitis.
Rhizoma Cimicifugae: hot, sweet, be slightly cold, return lung, spleen, stomach, large intestine channel.Deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.For headache due to pathogenic wind-heat, measles without adequate eruption, laryngopharynx swelling and pain, collapse of QI, chronic diarrhea proctoptosis, metrostaxis etc.
Periostracum Cicadae: sweet, cold, return lung, Liver Channel.Dispelling wind and heat pathogens, rash is antipruritic, relieving convulsion.For conjunctival congestion cataracta, infantile convulsion night cry etc.
Rhizoma Et Radix Notopterygii: acrid, bitter, warm.Return bladder, kidney channel.Cold expelling dispels the wind, removing dampness to relieve pain.For anemofrigid cold, headache general pain, rheumatic arthralgia, shoulder pain etc.
Mumps is by the caused a kind of acute infectious disease of mumps virus, take heating, cheek to swell and ache as feature.The Herba Buddlejae Lindleyanae removing toxic substances of dispeling the wind in the present invention, Radix Isatidis heat-clearing and toxic substances removing, Drymoglossum Herba Drymoglossi heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, the Radix Bupleuri evacuation is brought down a fever, the resolving depression eliminating stagnation, Herba Duchesneae Indicae heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, Rhizoma Menispermi heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, the Folium Hibisci Rosae-Sinensis heat-clearing and toxic substances removing, Periostracum Cicadae dispelling wind and heat pathogens, notopterygium wind dispelling removing toxic substances.All medicines share the effect of playing altogether antipyretic-antalgic, heat-clearing and toxic substances removing, resolving depression eliminating stagnation, through clinical practice, find that mumps is had to unique curative effect.
Chinese medicine composition of the present invention was in 2006 to 2010 the routine patients of clinical observation mumps 80, and clinical report is as follows:
1, physical data
In 80 routine patients, age 5-16 year, the course of disease is many at 2-7 days, 12 years old mean age.
2, diagnostic criteria
" traditional Chinese medical science disease Standardization of diagnosis and curative effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
2.1 during onset, heating can be arranged, 1～2 day is unrestrained swollen centered by ear-lobe as seen afterwards, blur margin, and color of the leather is not red, and having of pressure keenly felt and elastic sensation, usually first sees a side, then sees opposite side.
2.2 orifice of parotid duct or visible red and swollen.Swelling of parotid gland approximately continues to start to disappear in 4～5 days, the whole course of disease approximately 1～2 week.
2.3 the mumps contact history is arranged before disease.
2.4 the blood leukocytes sum can be normal, or slightly have and increase and reduce, lymphocyte can increase relatively.
2.5 incidence of meningitis or encephalitis person, cerebrospinal pressure increases, and cell number increases, and take lymphocyte as main, and normally, albumen slightly increases for chloride, sugar.
2.6 urine and blood amylase can increase.
3, Therapeutic Method
3.1 prescription: Herba Buddlejae Lindleyanae 40g, Radix Isatidis 30g, Drymoglossum Herba Drymoglossi 25g, Radix Bupleuri 20g, Herba Duchesneae Indicae 20g, Rhizoma Menispermi 20g, Folium Hibisci Rosae-Sinensis 15g, Rhizoma Cimicifugae 15g, Periostracum Cicadae 10g, Rhizoma Et Radix Notopterygii 10g.
3.2 method of preparation and use: said medicine technique is routinely made decoction, 1 dose of every day, every day 2 times, within 3 days, is 1 course for the treatment of.
4, therapeutic outcome:
4.1 formulate with reference to " Chinese medicine Clinical Researches of New Drugs guideline ":
Cure: body temperature is normal, and mumps disappears fully, without complication.
Take a turn for the better: mumps and all diseases alleviate.
Do not heal: mumps has no improvement, or deteriorated case occurs.
4.2 result: in 80 routine patients, clinical cure 70 examples (87.5%), produce effects 10 examples (12.5%), invalid 0 example, total effective rate is 100%.
5, model case
5.1 Chen, man, 9 years old.The both sides cheek is unrestrained swelling 3 days centered by ear-lobe, flexible sense, blur margin.Local colour of skin flushing, touch a tender spot obviously in centre.Dehisce and dysmasesis, the liquid of only taking food.Fever, headache, aversion to cold, lethargy, red tip of the tongue, tongue are thick in vain, full and rapid pulse.Be diagnosed as mumps.Take medicine of the present invention, treat 1 course for the treatment of, symptom obviously alleviates, and continues to take 2 courses for the treatment of, recovery from illness.
5.2 grandson, female, 8 years old.Centered by auris dextra hangs down, right mumps is large, touches a tender spot obviously in centre.The routine blood test no abnormality seen, pharyngeal slightly red, dysphagia, the liquid of only taking food, red tongue with thin fur, rapid pulse.Be diagnosed as mumps.Take medicine of the present invention, 1 dose of every day, after 1 course for the treatment of, symptom is clearly better, and continues to take 2 courses for the treatment of, recovery from illness.
5.3 Liu, the female, 10 years old, swollen hard pain under the ear of left side, mild pain under the ear of right side, not hard, fever, slight aversion to cold, tired, vomiting, dysphagia, the liquid of only taking food.Orifice of parotid duct redness in cheek, thirsty constipation, red tongue, yellow fur, rapid pulse are shown in inspection.Take medicine of the present invention, 1 dose of every day, after 1 course for the treatment of, symptom is clearly better, and continues to take 1 course for the treatment of, recovery from illness.
The specific embodiment
Below in conjunction with embodiment, the present invention is further illustrated, and following this embodiment does not only limit the present invention for the present invention is described.
Embodiment 1, and a kind of Chinese medicine composition for the treatment of mumps is to be made by Herba Buddlejae Lindleyanae 30g, Radix Isatidis 20g, Drymoglossum Herba Drymoglossi 20g, Radix Bupleuri 10g, Herba Duchesneae Indicae 15g, Rhizoma Menispermi 15g, Folium Hibisci Rosae-Sinensis 10g, Rhizoma Cimicifugae 10g, Periostracum Cicadae 8g, Rhizoma Et Radix Notopterygii 8g.
Embodiment 2, and a kind of Chinese medicine composition for the treatment of mumps is to be made by Herba Buddlejae Lindleyanae 40g, Radix Isatidis 30g, Drymoglossum Herba Drymoglossi 25g, Radix Bupleuri 20g, Herba Duchesneae Indicae 20g, Rhizoma Menispermi 20g, Folium Hibisci Rosae-Sinensis 15g, Rhizoma Cimicifugae 15g, Periostracum Cicadae 10g, Rhizoma Et Radix Notopterygii 10g.
Embodiment 3, and a kind of Chinese medicine composition for the treatment of mumps is to be made by Herba Buddlejae Lindleyanae 50g, Radix Isatidis 40g, Drymoglossum Herba Drymoglossi 30g, Radix Bupleuri 30g, Herba Duchesneae Indicae 25g, Rhizoma Menispermi 25g, Folium Hibisci Rosae-Sinensis 20g, Rhizoma Cimicifugae 20g, Periostracum Cicadae 15g, Rhizoma Et Radix Notopterygii 15g.
Claims (2)
1. a Chinese medicine composition for the treatment of mumps is characterized in that it is to be made by following raw material medicaments:
Herba Buddlejae Lindleyanae 30-50 part, Radix Isatidis 20-40 part, Drymoglossum Herba Drymoglossi 20-30 part, Radix Bupleuri 10-30 part, Herba Duchesneae Indicae 15-25 part, Rhizoma Menispermi 15-25 part, Folium Hibisci Rosae-Sinensis 10-20 part, Rhizoma Cimicifugae 10-20 part, Periostracum Cicadae 8-15 part, Rhizoma Et Radix Notopterygii 8-15 part.
2. Chinese medicine composition according to claim 1 is characterized in that it is to be made by following raw material medicaments:
40 parts of Herba Buddlejae Lindleyanaes, 30 parts of Radix Isatidis, 25 parts of Drymoglossum Herba Drymoglossis, 20 parts of Radix Bupleuri, 20 parts of Herba Duchesneae Indicaes, 20 parts of Rhizoma Menispermis, 15 parts of Folium Hibisci Rosae-Sinensiss, 15 parts of Rhizoma Cimicifugaes, 10 parts of Periostracum Cicadaes, 10 parts of Rhizoma Et Radix Notopterygiis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102912239A CN102772511B (en) | 2012-08-08 | 2012-08-08 | Traditional Chinese medicine composition for treating mumps |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102912239A CN102772511B (en) | 2012-08-08 | 2012-08-08 | Traditional Chinese medicine composition for treating mumps |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102772511A CN102772511A (en) | 2012-11-14 |
| CN102772511B true CN102772511B (en) | 2013-12-11 |
Family
ID=47117768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102912239A Active CN102772511B (en) | 2012-08-08 | 2012-08-08 | Traditional Chinese medicine composition for treating mumps |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102772511B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103638182B (en) * | 2013-11-26 | 2016-01-20 | 武宝通 | The Chinese medicine for outer use for the treatment of acute lymphadenitis |
| CN103784807B (en) * | 2014-03-11 | 2016-02-24 | 陈广敏 | One treats the parotitic Chinese medicine of damp-heat type |
| CN104435170A (en) * | 2014-11-22 | 2015-03-25 | 李任 | Traditional Chinese medicine for treating mumps |
| CN104523895A (en) * | 2014-11-22 | 2015-04-22 | 李任 | Traditional Chinese medicine for treating parotitis |
| CN104435199A (en) * | 2014-11-22 | 2015-03-25 | 李任 | Traditional Chinese medicine preparation for treating mumps with aristolochia championii |
| CN106177121A (en) * | 2016-08-16 | 2016-12-07 | 安徽天乾健食品科技有限公司 | One treats parotitic Chinese medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102327381A (en) * | 2011-09-16 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | Chinese herbal medicine for treating mumps |
-
2012
- 2012-08-08 CN CN2012102912239A patent/CN102772511B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102327381A (en) * | 2011-09-16 | 2012-01-25 | 重庆市南川区瑞丰农业开发有限责任公司 | Chinese herbal medicine for treating mumps |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102772511A (en) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772511B (en) | Traditional Chinese medicine composition for treating mumps | |
| CN102784282A (en) | Medicine for clearing heat, removing toxicity and reducing fever | |
| CN103610987B (en) | Traditional Chinese medicine for treating mumps | |
| CN104257778B (en) | A kind of Chinese medicine treating rheumatic arthritis | |
| CN104147194B (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN103830357B (en) | Traditional Chinese medicine for treating heat-toxicity type parotitis | |
| CN103550515A (en) | Traditional Chinese medicine composition for treating epidemic parotitis | |
| CN103610915B (en) | Traditional Chinese medicine for treating swelling and pain in throat | |
| CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN102935174B (en) | Traditional Chinese medicine composition for treating parotitis | |
| CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
| CN104825903A (en) | Traditional Chinese medicine for treating mumps and method for manufacturing traditional Chinese medicine | |
| CN104740036A (en) | Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea | |
| CN104288635A (en) | Traditional Chinese medicine preparation for treating wind-cold attacking lung type cough | |
| CN102940739B (en) | Traditional Chinese medicine composition for treating vernal keratoconjunctivitis | |
| CN103536732A (en) | Traditional Chinese medicine composition for treating chronic pyogenic parotitis | |
| CN103751553B (en) | One treats the parotitic Chinese medicine of anemopyretic | |
| CN104771498A (en) | Traditional Chinese medicine composition for treating mumps caused by accumulated toxic heat | |
| CN103784807B (en) | One treats the parotitic Chinese medicine of damp-heat type | |
| CN102824450B (en) | Externally-applied medicine for treating psoriasis and preparation method thereof | |
| CN103599498B (en) | Traditional Chinese medicine composition for treating pathogenic wind-heat staying within eyelid type keratoconjunctivitis | |
| CN102872269B (en) | Traditional Chinese medicine composition for treating infantile acute tonsillitis | |
| CN105055795A (en) | Drug for treating toxic heat type mumps | |
| CN104622988A (en) | Traditional Chinese medicine composition for treating warm toxin assailing type mumps | |
| CN105079561A (en) | Traditional Chinese medicine for treating damp-heat type parotitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GAO YUHONG Effective date: 20140911 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262500 WEIFANG, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140911 Address after: 226200 chemical industry park, Nantong, Jiangsu, Qidong Patentee after: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Address before: 262500 Shandong province Qingzhou City Linglong Mountain Road No. 4138 Weifang Yidu Central Hospital Patentee before: Gao Yuhong |